Evidence map›Paper›PMID 34771502›Full record

ArticleCancers2021

Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care.

Pablo Gargallo, Silvestre Oltra, Yania Yáñez, Antonio Juan-Ribelles, Inés Calabria, Vanessa Segura, Marián Lázaro, Julia Balaguer, Teresa Tormo, Sandra Dolz and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Germline Variants in Pediatric Cancer : Based on Oncogenic Pathways.Journal of Korean Neurosurgical Society · 2025
    Article
  4. Article
  5. Cancers · 2023
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Pablo GargalloPediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.ORCID 0000-0001-9720-8542
Silvestre OltraGenetics Unit, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.
Yania YáñezPediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.
Antonio Juan-RibellesPediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.ORCID 0000-0002-2662-7632
Inés CalabriaImegen-Health in Code Group, Department of Oncology, Paterna, 46980 Valencia, Spain.
Vanessa SeguraPediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.
Marián LázaroImegen-Health in Code Group, Department of Oncology, Paterna, 46980 Valencia, Spain.
Julia BalaguerPediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.
Teresa TormoPediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.
Sandra DolzLaboratory of Cellular and Molecular Biology, Clinical and Translational Research in Cancer, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
José María FernándezPediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.
Carolina FuentesPediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.
Bárbara TorresPediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.
Mara AndrésPediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.
María TassoPediatric Oncology Department, Hospital General de Alicante, 03010 Alicante, Spain.ORCID 0000-0002-0641-930X
Victoria CastelPediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.ORCID 0000-0002-3792-0615
Jaime Font de MoraLaboratory of Cellular and Molecular Biology, Clinical and Translational Research in Cancer, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.ORCID 0000-0002-6816-2095
Adela CañetePediatric Oncology Department, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.ORCID 0000-0002-5669-5097
Hospital Universitari i Politècnic La Fe · ESInstituto de Investigación Sanitaria La Fe · ESInstituto de Medicina Genómica · ESUniversitat de València · ESHospital General Universitario de Alicante Doctor Balmis · ES

Funding

Instituto de Investigación Sanitaria La Fe post-residents grant
6 · The paper itself

Abstract

Knowledge about genetic predisposition to pediatric cancer is constantly expanding. The categorization and clinical management of the best-known syndromes has been refined over the years. Meanwhile, new genes for pediatric cancer susceptibility are discovered every year. Our current work shares the results of genetically studying the germline of 170 pediatric patients diagnosed with cancer. Patients were prospectively recruited and studied using a custom panel,

Indexed as

genetic counselinggenetic predispositiongenetic syndromegermlinehereditary cancerpediatric oncologyworking tool

Identifiers

PMID34771502
PMCPMC8582391
OpenAlexW3210670467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.